Messenger RNA is the technology behind the medicines and vaccines that Moderna, a biotechnology company, develops. Its marketed products include a vaccine against the coronavirus that causes COVID and a vaccine for respiratory syncytial virus. Its research pipeline covers infectious disease, cancer and rare conditions. Customers are governments, health systems, pharmacies and distributors that purchase its vaccines.
Vaccine supply to governments and healthcare providers is the main source of revenue, together with some collaboration income. Revenue was $2.2 billion over the last twelve months and has changed at -53.4% a year across the last three years, a very steep decline. The operating margin is -149.0%, a large operating loss, and the business earns -91% on the capital invested in it. No dividend is paid. On the site's X-Ray Score it receives 13 out of 100.
Written with AI from public information and the filing figures on this page, then checked automatically for unsupported numbers. It can contain mistakes: read the company's own filings below before relying on it.
52-wk range $22.28 – $242.29Volume 21,368,200Daily, split-adjusted
Vitals
Market cap$86.8B
52-week range$22.28 – $242.29
Volume (last day)21,368,200
P/E (TTM)–
EBIT / EV yield-4.0%
Free-cash-flow yield-1.4%
Dividend yieldNo dividend
Revenue (TTM)$2.2B
Net income (TTM)−$3.2B
Operating margin-149.0%
Return on capital-91.3%
Debt incl. leases$1.3B
Cash & securities$5.1B
Debt = borrowings plus lease liabilities. Cash & securities = cash, equivalents and short-term marketable securities (long-term securities are not counted, so net cash can be understated for companies like Apple). Net debt = debt minus cash & securities. Source: latest SEC 10-Q/10-K. EBIT / EV yield = operating profit divided by market cap plus net debt.
Fair value estimate
Not rated
Loss-making or insufficient history: no DCF/EPV
What this means
Read the lenses below
A high score does not guarantee a good outcome; it shifts the odds a little. Use the checklist as a prompt for your own research.
Before you invest · decision checklist
Ticked boxes are filled in from our data; the rest are yours to answer.
The five-lens scan
Every score explained in one sentence, ranked against Health Care peers. Open a lens to see the numbers behind it.
ValuationWeak
3/100
Expensive against its sector on earnings and cash flow.
See the numbers →
EBIT / EV yield-4.0%
Free-cash-flow yield-1.4%
GrowthWeak
1/100
Growing slower than most of its sector.
See the numbers →
Revenue growth (3y)-53.4%
Growth consistency30%
ProfitabilityWeak
18/100
Earns lower returns on its capital than most peers.
See the numbers →
Return on invested capital-91.3%
Operating margin-149.0%
Gross profitability4.8%
Financial healthWeak
28/100
Balance sheet is more stretched than most peers.
See the numbers →
Piotroski F-Score3 / 9
DividendsNone
–/100
Pays no dividend.
See the numbers →
Quarterly results: last 6 quarters
-35.3%Mar '25
-41.1%Jun '25
-45.4%Sep '25
-29.8%Dec '25
+260.2%Mar '26
+2.1%Jun '26
Revenue against the same quarter a year earlier. Latest quarter revenue $145M, diluted EPS $-1.97.
Each check is graded against the company's sector, not a fixed number. Checklist score 24/100.
Financials
FY21
FY22
FY23
FY24
FY25
Revenue
$18.5B
$19.3B
$6.8B
$3.2B
$1.9B
Operating income
$13.3B
$9.4B
−$4.2B
−$3.9B
−$3.1B
Net income
$12.2B
$8.4B
−$4.7B
−$3.6B
−$2.8B
Operating cash flow
$13.6B
$5.0B
−$3.1B
−$3.0B
−$1.9B
Operating margin
72.0%
48.9%
-61.9%
-121.9%
-158.1%
Free cash flow
$13.3B
$4.6B
−$3.8B
−$4.1B
−$2.1B
Diluted EPS
$28.29
$20.12
$-12.33
$-9.28
$-7.26
Fiscal years, from SEC filings.
Technical summary
Daily
Strongly bullish
12 bullish · 3 neutral · 1 bearish
Weekly
Strongly bullish
11 bullish · 0 neutral · 1 bearish
Monthly
Strongly bullish
7 bullish · 0 neutral · 1 bearish
Moving averages (daily)
SMA 10
212.0
Bullish
EMA 10
213.7
Bullish
SMA 20
201.2
Bullish
EMA 20
199.2
Bullish
SMA 50
154.9
Bullish
EMA 50
162.1
Bullish
SMA 100
107.0
Bullish
EMA 100
126.0
Bullish
SMA 200
77.40
Bullish
EMA 200
93.27
Bullish
Oscillators (daily)
RSI (14)
61.67
Neutral
MACD (12, 26)
20.00
Bullish
Momentum (12)
13.21
Bullish
Stochastic %K (14)
59.39
Neutral
Williams %R (14)
-40.61
Neutral
CCI (20)
117.7
Bearish
Pivot points (classic, last session)
S3
176.3
S2
192.6
S1
205.3
Pivot
221.6
R1
234.3
R2
250.7
R3
263.4
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.